Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis
2018 ◽
Vol 30
(1)
◽
pp. 1-9
2019 ◽
Vol 13
(11)
◽
pp. 1087-1094
◽